|
It has been said that there is good fishing in troubled waters and that has been the case with fraudsters seeking to profit from anxiety and fears associated with COVID-19. Accordingly, the U.S. Food and Drug Administration is on the lookout for charlatans seeking to profit from the pandemic.
Public health protection for consumers is the hallmark of our mission, and the FDA remains vigilant to protect consumers from fraud, which undermines public confidence in legitimate COVID-19 vaccine efforts. While vaccine distribution is underway throughout the country, schemes and unsavory efforts to mislead and scam the American public are plentiful.
The FDA is well-equipped to identify and thwart medical product scams. The Office of Regulatory Affairs’ Health Fraud Branch, the Office of Criminal Investigations (OCI), and the Office of Enforcement and Import Operations work collaboratively with colleagues in the FDA’s medical product centers, the FDA’s Office of Chief Counsel, and the HHS Office of Minority Health, as well as other government agencies such as U.S. Customs and Border Protection and the U.S. Department of Justice.
|
|
|
|